Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 521

1.

A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.

Hojo M, Nagahara A, Asaoka D, Takeda T, Izumi K, Matsumoto K, Ueyama H, Shimada Y, Matsumoto K, Nojiri S, Watanabe S.

Digestion. 2017;96(1):5-12. doi: 10.1159/000477345. Epub 2017 Jun 13.

2.

Efficacy of Mentha pulegium extract in the treatment of functional dyspepsia: A randomized double-blind placebo-controlled clinical trial.

Khonche A, Fallah Huseini H, Abdi H, Mohtashami R, Nabati F, Kianbakht S.

J Ethnopharmacol. 2017 Jul 12;206:267-273. doi: 10.1016/j.jep.2017.05.026. Epub 2017 May 30.

PMID:
28571727
3.

Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial.

Hsu PI, Wu DC, Tsay FW, Cheng JS, Liu CP, Lai KH, Chen WC, Wang HM, Tsai TJ, Tsai KW, Kao SS.

Am J Gastroenterol. 2017 Feb;112(2):282-289. doi: 10.1038/ajg.2016.526. Epub 2016 Dec 6.

PMID:
27922030
4.

Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.

Chan FK, Kyaw M, Tanigawa T, Higuchi K, Fujimoto K, Cheong PK, Lee V, Kinoshita Y, Naito Y, Watanabe T, Ching JY, Lam K, Lo A, Chan H, Lui R, Tang RS, Sakata Y, Tse YK, Takeuchi T, Handa O, Nebiki H, Wu JC, Abe T, Mishiro T, Ng SC, Arakawa T.

Gastroenterology. 2017 Jan;152(1):105-110.e1. doi: 10.1053/j.gastro.2016.09.006. Epub 2016 Sep 15.

PMID:
27641510
5.

Characteristics of the Human Upper Gastrointestinal Contents in the Fasted State Under Hypo- and A-chlorhydric Gastric Conditions Under Conditions of Typical Drug - Drug Interaction Studies.

Litou C, Vertzoni M, Goumas C, Vasdekis V, Xu W, Kesisoglou F, Reppas C.

Pharm Res. 2016 Jun;33(6):1399-412. doi: 10.1007/s11095-016-1882-8. Epub 2016 Mar 14.

PMID:
26975361
6.

Effects of high levels of dietary zinc oxide on ex vivo epithelial histamine response and investigations on histamine receptor action in the proximal colon of weaned piglets.

Kröger S, Pieper R, Aschenbach JR, Martin L, Liu P, Rieger J, Schwelberger HG, Neumann K, Zentek J.

J Anim Sci. 2015 Nov;93(11):5265-72. doi: 10.2527/jas.2015-9095.

PMID:
26641046
7.

The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin.

Hibma JE, Zur AA, Castro RA, Wittwer MB, Keizer RJ, Yee SW, Goswami S, Stocker SL, Zhang X, Huang Y, Brett CM, Savic RM, Giacomini KM.

Clin Pharmacokinet. 2016 Jun;55(6):711-21. doi: 10.1007/s40262-015-0346-3.

8.

Mitigation of Adverse Clinical Events of a Narrow Target Therapeutic Index Compound through Modified Release Formulation Design: An in Vitro, in Vivo, in Silico, and Clinical Pharmacokinetic Analysis.

Good DJ, Hartley R, Mathias N, Crison J, Tirucherai G, Timmins P, Hussain M, Haddadin R, Koo O, Nikfar F, Fung NK.

Mol Pharm. 2015 Dec 7;12(12):4434-44. doi: 10.1021/acs.molpharmaceut.5b00624. Epub 2015 Nov 4.

PMID:
26536519
9.

Gastroprotective efficacy and safety of single-tablet ibuprofen/famotidine vs ibuprofen in older persons.

Bello AE, Kent JD, Holt RJ.

Phys Sportsmed. 2015 Jul;43(3):193-9. doi: 10.1080/00913847.2015.1066229. Epub 2015 Jul 13.

PMID:
26165391
10.

Comparison of the Effect of Pre-operative Single Oral Dose of Tramadol and Famotidine on Gastric Secretions pH and Volume in Patients Scheduled for Laparoscopic Cholecystectomy.

Khan MU, Aqil M, Hussain A, Zahrani TA, Hillis M.

J Coll Physicians Surg Pak. 2015 May;25(5):320-3. doi: 05.2015/JCPSP.320323.

PMID:
26008654
11.

Efficacy of intravenous administration of combined acid suppressants in healthy dogs.

Tolbert MK, Odunayo A, Howell RS, Peters EE, Reed A.

J Vet Intern Med. 2015 Mar-Apr;29(2):556-60. doi: 10.1111/jvim.12555. Epub 2015 Feb 25.

12.

Evaluation of the effect of orally administered acid suppressants on intragastric pH in cats.

Parkinson S, Tolbert K, Messenger K, Odunayo A, Brand M, Davidson G, Peters E, Reed A, Papich MG.

J Vet Intern Med. 2015 Jan;29(1):104-12. doi: 10.1111/jvim.12493. Epub 2014 Dec 24.

13.

Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III Trial.

Kim EH, Lee YC, Chang YW, Park JJ, Chun HJ, Jung HY, Kim HS, Jeong HY, Seol SY, Han SW, Choi MG, Park SH, Lee OJ, Jung JT, Lee DH, Jung HC, Lee ST, Kim JG, Youn SJ, Kim HY, Lee SW.

Dig Dis Sci. 2015 Jun;60(6):1724-32. doi: 10.1007/s10620-014-3489-4. Epub 2014 Dec 23.

PMID:
25532503
14.

Comparison of teprenone and famotidine against gastroduodenal mucosal damage in patients taking low-dose aspirin.

Takeuchi T, Ota K, Harada S, Kojima Y, Inoue T, Iwakiri R, Sakata Y, Fujimoto K, Fujita T, Azuma T, Higuchi K.

J Gastroenterol Hepatol. 2014 Dec;29 Suppl 4:11-5. doi: 10.1111/jgh.12768.

PMID:
25521726
15.

One-year safety of ibuprofen/famotidine fixed combination versus ibuprofen alone: pooled analyses of two 24-week randomized, double-blind trials and a follow-on extension.

Bello AE, Grahn AY, Ball J, Kent JD, Holt RJ.

Curr Med Res Opin. 2015 Mar;31(3):407-20. doi: 10.1185/03007995.2014.1000086. Epub 2015 Jan 12.

PMID:
25516006
16.

One-year open-label safety evaluation of the fixed combination of ibuprofen and famotidine with a prospective analysis of dyspepsia.

Bello AE, Kent JD, Grahn AY, Ball J, Holt RJ.

Curr Med Res Opin. 2015 Mar;31(3):397-405. doi: 10.1185/03007995.2014.999152. Epub 2015 Jan 9.

PMID:
25495134
17.

Phase I study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid tumors.

Dickson MA, Gordon MS, Edelman G, Bendell JC, Kudchadkar RR, LoRusso PM, Johnston SH, Clary DO, Schwartz GK.

Invest New Drugs. 2015 Apr;33(2):349-56. doi: 10.1007/s10637-014-0191-5. Epub 2014 Dec 5.

PMID:
25476894
18.

Effect of proton pomp inhibitor (PPI : Rabeprazole) on reflux esophagitis after endoscopic injection sclerotherapy (EIS), a randomized control study (24 hour-pH monitoring).

Akahoshi T, Kawanaka H, Tomikawa M, Saeki H, Uchiyama H, Ikeda T, Shirabe K, Hashizume M, Maehara Y.

Fukuoka Igaku Zasshi. 2013 Dec;104(12):483-9.

PMID:
24693675
19.

A phase I study of oral ixabepilone in patients with advanced solid tumors.

Deeken JF, Marshall JL, Pishvaian MJ, Hwang J, Ahlers CM, Clemens PL, Parker SM, Iacono L, LoRusso PM.

Cancer Chemother Pharmacol. 2014 May;73(5):1071-8. doi: 10.1007/s00280-014-2443-7. Epub 2014 Mar 25.

PMID:
24663504
20.

Famotidine as a radioprotector for rectal mucosa in prostate cancer patients treated with radiotherapy: phase I/II randomized placebo-controlled trial.

Razzaghdoust A, Mozdarani H, Mofid B.

Strahlenther Onkol. 2014 Aug;190(8):739-44. doi: 10.1007/s00066-014-0602-8. Epub 2014 Mar 12.

PMID:
24619016

Supplemental Content

Loading ...
Support Center